David Schmidt - Aug 14, 2024 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Director
Signature
/s/ John Vong, as Attorney-in-Fact
Stock symbol
ASTH
Transactions as of
Aug 14, 2024
Transactions value $
-$485,382
Form type
4
Date filed
8/16/2024, 04:15 PM
Previous filing
Aug 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Options Exercise $169K +11K +118.1% $15.35* 20.3K Aug 14, 2024 Direct
transaction ASTH Common Stock Options Exercise $62.8K +3.41K +16.78% $18.41* 23.7K Aug 14, 2024 Direct
transaction ASTH Common Stock Disposed to Issuer -$717K -14.4K -60.74% $49.76 9.31K Aug 16, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASTH Stock Option (right to buy) Options Exercise $0 -11K -100% $0.00* 0 Aug 14, 2024 Common Stock 11K $15.35 Direct F3
transaction ASTH Stock Option (right to buy) Options Exercise $0 -3.41K -100% $0.00* 0 Aug 14, 2024 Common Stock 3.41K $18.41 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were repurchased by the Issuer.
F2 Includes 5,750 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders.
F3 These stock options were fully vested and exercisable.